Billionaires Holding AVEO

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 51.8M
    Shares Outstanding

  • 57.42M
    Market Cap

News & Insights

ABOUT

AVEO

Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.

Introducing The Vanguard REIT Index Fund

NEWS

Why Robo Advisors Are The Future

READ MORE